Aredia

In the US, Aredia (pamidronate systemic) is a member of the drug class bisphosphonates and is used to treat Breast Cancer - Bone Metastases, Hypercalcemia, Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma and Paget's Disease.

US matches:

• Aredia

UK matches:

• Aredia Dry Powder
• AREDIA Dry Powder 15mg, 30mg and 90mg (SPC)

Ingredient matches for Aredia

Pamidronic Acid

Pamidronic Acid is reported as an ingredient of Aredia in the following countries:

• Japan


• Tunisia

Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Aredia in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Canada


• China


• Croatia (Hrvatska)


• Denmark


• Estonia


• Georgia


• Germany


• Ghana


• Greece


• Guyana


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Kenya


• Libya


• Luxembourg


• Malaysia


• Malta


• Nigeria


• Oman


• Peru


• Philippines


• Poland


• Romania


• Russian Federation


• Serbia


• Slovakia


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sudan


• Switzerland


• Taiwan


• Tanzania


• Thailand


• Turkey


• United Kingdom


• United States


• Vietnam


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.